✦ LIBER ✦

Clinical Presentation and Personality Factors Are Predictors of the Response to Treatment in Patients with Functional Dyspepsia: A Randomized, Double-Blind Placebo-Controlled Crossover Study

✍ Scribed by Gerald Holtmann; Sven-Uwe Kutscher; Sebastian Haag; Mathias Langkafel; Gereon Heuft; Jutta Neufang-Hueber; Harald Goebell; Wolfgang Senf; Nicholas J. Talley

Book ID: 111578893
Publisher: Springer US
Year: 2004
Tongue: English
Weight: 58 KB
Volume: 49
Category: Article
ISSN: 0163-2116
DOI: 10.1023/b:ddas.0000026317.00071.75

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Randomised clinical trial: the effects o

Randomised clinical trial: the effects of amitriptyline on drinking capacity and symptoms in patients with functional dyspepsia, a double-blind placebo-controlled study

✍ B. Braak; T. K. Klooker; M. M. Wouters; A. Lei; R. M. van den Wijngaard; G. E. B 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 305 KB

Randomised clinical trial: efficacy of L

Randomised clinical trial: efficacy of Lactobacillus paracasei-enriched artichokes in the treatment of patients with functional constipation – a double-blind, controlled, crossover study

✍ G. Riezzo; A. Orlando; B. D'Attoma; V. Guerra; F. Valerio; P. Lavermicocca; S. D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 279 KB

One-week acid suppression trial in uninv

One-week acid suppression trial in uninvestigated dyspepsia patients with epigastric pain or burning to predict response to 8 weeks’ treatment with esomeprazole: a randomized, placebo-controlled study

✍ S. V. VAN ZANTEN; N. FLOOK; N. J. TALLEY; N. VAKIL; K. LAURITSEN; E. BOLLING-STE 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Randomised clinical trial: efficacy of t

Randomised clinical trial: efficacy of the addition of a prokinetic, mosapride citrate, to omeprazole in the treatment of patients with non-erosive reflux disease – a double-blind, placebo-controlled study

✍ H. Miwa; K. Inoue; K. Ashida; T. Kogawa; A. Nagahara; S. Yoshida; N. Tano; Y. Ya 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 227 KB

Tocilizumab inhibits structural joint da

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

✍ Joel M. Kremer; Ricardo Blanco; Marek Brzosko; Ruben Burgos-Vargas; Anne-Marie H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 3 views